The nicaraguan pediatric dengue cohort study: Study design, methods, use of information technology, and extension to other infectious diseases

American Journal of Epidemiology

Volumn 170, Issue 1, 2009, Pages 120-129

  Kuan, Guillermina ^b   Gordon, Aubree ^a   Avilés, William ^c   Ortega, Oscar ^c   Hammond, Samantha N ^c   Elizondo, Douglas ^c   Nuñez, Andrea ^d   Coloma, Josefina ^a   Balmaseda, Angel ^d   Harris, Eva ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Centro de Salud Socrates Flores Vivas   (Nicaragua)

^c Primero deMayo ^*  (Nicaragua)

^d Centro Nacional de Diagnostico y Referencia   (Nicaragua)

Author keywords

Central America; Cohort studies; Dengue; Information systems; Methods; Nicaragua

Indexed keywords

CHILD HEALTH; COHORT ANALYSIS; DENGUE FEVER; DESIGN; DISEASE TRANSMISSION; INFECTIOUS DISEASE; INFORMATION TECHNOLOGY; MOSQUITO; VIRAL DISEASE; VIRUS;

ARTICLE; BLOOD SAMPLING; CHILD; CONTROLLED STUDY; DENGUE; FEMALE; HUMAN; INFLUENZA; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MEDICAL CARE; MEDICAL INFORMATION SYSTEM; MORBIDITY; NICARAGUA; PRESCHOOL CHILD; SCHOOL CHILD; VIRAL RESPIRATORY TRACT INFECTION;

CHILD; CHILD, PRESCHOOL; DENGUE; FEMALE; FOLLOW-UP STUDIES; GEOGRAPHIC INFORMATION SYSTEMS; HEALTH SERVICES RESEARCH; HUMANS; INCIDENCE; INFORMATION MANAGEMENT; INFORMATION SYSTEMS; MALE; NICARAGUA; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; TECHNOLOGY ASSESSMENT, BIOMEDICAL; TIME FACTORS;

CENTRAL AMERICA; MANAGUA [NICARAGUA]; NICARAGUA;

DENGUE VIRUS;

EID: 67650034892     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwp092     Document Type: Article

References (20)

1. Gibbons RV, Vaughn DW. Dengue: an escalating problem. BMJ. 2002;324(7353):1563-1566.
2. Balmaseda A, Hammond SN, Tellez Y, et al. High seroprevalence of antibodies against dengue virus in a prospective study of schoolchildren in Managua, Nicaragua. Trop Med Int Health. 2006;11(6):935-942.
3. Endy TP, Chunsuttiwat S, Nisalak A, et al. Epidemiology of inapparent and symptomatic acute dengue virus infection: a prospective study of primary school children in Kamphaeng Phet, Thailand. Am J Epidemiol. 2002;156(1):40-51.
4. Burke DS, Nisalak A, Johnson DE, et al. A prospective study of dengue infections in Bangkok. Am J Trop Med Hyg. 1988; 38(1):172-180.
5. World Health Organization. Dengue Haemorrhagic Fever: Diagnosis, Treatment, Prevention, and Control. Geneva, Switzerland: World Health Organization; 1997.
6. Sabin AB. The dengue group of viruses and its family relationships. Bacteriol Rev. 1950;14(3):225-232.
7. Halstead SB. Epidemiology of dengue and dengue hemorrhagic fever. In: Gubler DJ, Kuno G, eds. Dengue and Dengue Hemorrhagic Fever. New York, NY: CAB International; 1997.
8. Hombach J. Vaccines against dengue: a review of current candidate vaccines at advanced development stages. Rev Panam Salud Publica. 2007;21(4):254-260.
9. Whitehead SS, Blaney JE, Durbin AP, et al. Prospects for a dengue virus vaccine. Nat Rev Microbiol. 2007;5(7): 518-528.
10. Guzmán MG, Kourí G. Dengue: an update. Lancet Infect Dis. 2002;2(1):33-12.
11. Balmaseda A, Sandoval E, Pérez L, et al. Application of molecular typing techniques in the 1998 dengue epidemic in Nicaragua. Am J Trop Med Hyg. 1999;61(6):893-897.
12. Lanciotti RS, Calisher CH, Gubler DJ, et al. Rapid detection and typing of dengue viruses from clinical samples by using reverse transcriptase- polymerase chain reaction. J Clin Microbiol. 1992;30(3):545-551.
13. Seah CL, Chow VT, Tan HC, et al. Rapid, single-step RT-PCR typing of dengue viruses using five NS3 gene primers. J Virol Methods. 1995;51(2-3):193-200.
14. Balmaseda A, Guzmán MG, Hammond S, et al. Diagnosis of dengue virus infection by detection of specific immunoglobulin M (IgM) and IgA antibodies in serum and saliva. Clin Diagn Lab Immunol. 2003;10(2):317-322.
15. Fernández RJ, Vázquez S. Serological diagnosis of dengue by an ELISA inhibition method (EIM). Mem Inst Oswaldo Cruz. 1990;85(3):347-351.
16. Reed LJ, Muench H. A simple method of estimating fifty percent endpoints. Am J Hyg. 1938;27(3):493-497.
17. Avilés W, Ortega O, Kuan G, et al. Integration of information technologies in clinical studies in Nicaragua. PLoS Med. 2007;4(10):1578-1583.
18. Avilés W, Ortega O, Kuan G, et al. Quantitative assessment of the benefits of specific information technologies applied to clinical studies in developing countries. Am J Trop Med Hyg. 2008;78(2):311-315.
19. Gordon A, Ortega O, Kuan G, et al. Prevalence and seasonality of influenza-like illness in children, Nicaragua, 2005-2007. Emerg Infect Dis. 2009;15(3):408-414.
20. Coloma J, Harris E. Sustainable transfer of biotechnology to developing countries: fighting poverty by bringing scientific tools to developing-country partners. Ann N Y Acad Sci. 2008;1136:358-368.